According to OKYO Pharma's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.14 Billion a decrease over its 2023 earnings that were of -HK$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -HK$0.14 Billion | 26.49% |
2023 | -HK$0.11 Billion | 113.65% |
2022 | -HK$48.39 Million | 33.88% |
2021 | -HK$36.14 Million | 131.68% |
2020 | -HK$15.6 Million | -68.65% |
2019 | -HK$49.77 Million | -83.86% |
2018 | -HK$0.31 Billion | 13023.7% |
2017 | -HK$2.35 Million | -79.21% |
2016 | -HK$11.3 Million | -34.39% |
2015 | -HK$17.23 Million | -90.45% |
2014 | -HK$0.19 Billion | 227.44% |
2013 | -HK$55.09 Million | -22.35% |
2012 | -HK$70.95 Million | 250.83% |
2011 | -HK$20.23 Million | -113.5% |
2010 | HK$0.14 B | -6.42% |
2009 | HK$0.16 B | -448.4% |
2008 | -HK$45.93 Million |